Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 RNA Vaccines”

609 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 609 results

Not applicableEnded earlyNCT04870411
What this trial is testing

Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics

Who this might be right for
Autoimmune DiseasesInflammatory Disorder
Assistance Publique - Hôpitaux de Paris 78
Testing effectiveness (Phase 2)WithdrawnNCT05950776
What this trial is testing

COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults

Who this might be right for
Covid19
Universitätsklinikum Hamburg-Eppendorf
Not applicableUnknownNCT05126550
What this trial is testing

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

Who this might be right for
COVID-19
PT. Kimia Farma (Persero) Tbk 435
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07567274
What this trial is testing

DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury

Who this might be right for
Tinnitus
Leading Edge Clinic 20
Early research (Phase 1)Study completedNCT07095231
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)UnknownNCT05329051
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Sinocelltech Ltd. 400
Early research (Phase 1)UnknownNCT05007275
What this trial is testing

Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers

Who this might be right for
Covid19SARS-CoV-2 Infection
Imperial College London 28
Large-scale testing (Phase 3)Study completedNCT04470427
What this trial is testing

Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 30,415
Not applicableStudy completedNCT06113692
What this trial is testing

A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine

Who this might be right for
Myocarditis, Pericarditis
ModernaTX, Inc. 1,169
Not applicableUnknownNCT05150834
What this trial is testing

Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines

Who this might be right for
MicrobiomeVaccineCovid-19+2 more
Korea University Guro Hospital 53
Testing effectiveness (Phase 2)WithdrawnNCT05663086
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd.
Large-scale testing (Phase 3)UnknownNCT04659239
What this trial is testing

The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

Who this might be right for
COVID-19
Chinese Academy of Medical Sciences 34,020
Not applicableStudy completedNCT05621239
What this trial is testing

Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia People

Who this might be right for
COVID-19
Pfizer 260
Early research (Phase 1)UnknownNCT05839236
What this trial is testing

COVID-19 Vaccination Detoxification in LDL-C

Who this might be right for
COVID-19 Stress SyndromeCOVID-19 Vaccine Adverse ReactionCOVID-19-Associated Thromboembolism+3 more
Yang I. Pachankis 1
Post-approval studies (Phase 4)Study completedNCT05343871
What this trial is testing

Immunogenicity and Safety of Fractional Booster Dose of COVID-19 Vaccines Available for Use in Pakistan/Brazil: A Phase 4 Dose-optimizing Trial

Who this might be right for
COVID-19
Albert B. Sabin Vaccine Institute 2,354
Not applicableStudy completedNCT05244330
What this trial is testing

Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)

Who this might be right for
SARS CoV 2 Infection
First Affiliated Hospital Xi'an Jiaotong University 1,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06672055
What this trial is testing

Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

Who this might be right for
SARS-CoV2COVID-19
Vaxart 5,485
Post-approval studies (Phase 4)Study completedNCT05030974
What this trial is testing

RECOVAC Repeated Vaccination Study

Who this might be right for
Covid19Kidney DiseasesVaccine Response Impaired+1 more
University Medical Center Groningen 336
Not applicableActive Not RecruitingNCT04852289
What this trial is testing

A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans

Who this might be right for
COVID-19
National Institute on Aging (NIA) 78
Testing effectiveness (Phase 2)Study completedNCT04527081
What this trial is testing

Study of COVID-19 DNA Vaccine (AG0302-COVID19)

Who this might be right for
COVID-19
AnGes, Inc. 30
Next Page